AIRLINK 175.55 Decreased By ▼ -2.01 (-1.13%)
BOP 11.01 Decreased By ▼ -0.04 (-0.36%)
CNERGY 8.29 Increased By ▲ 0.12 (1.47%)
FCCL 47.23 Decreased By ▼ -0.09 (-0.19%)
FFL 16.02 Decreased By ▼ -0.10 (-0.62%)
FLYNG 27.31 Decreased By ▼ -0.04 (-0.15%)
HUBC 142.32 Decreased By ▼ -4.59 (-3.12%)
HUMNL 13.30 Decreased By ▼ -0.21 (-1.55%)
KEL 4.44 Decreased By ▼ -0.06 (-1.33%)
KOSM 5.90 Decreased By ▼ -0.01 (-0.17%)
MLCF 61.80 Decreased By ▼ -0.22 (-0.35%)
OGDC 226.77 Decreased By ▼ -7.91 (-3.37%)
PACE 5.77 Decreased By ▼ -0.03 (-0.52%)
PAEL 44.80 Decreased By ▼ -1.61 (-3.47%)
PIAHCLA 17.88 Decreased By ▼ -0.24 (-1.32%)
PIBTL 10.47 Decreased By ▼ -0.10 (-0.95%)
POWER 12.02 Increased By ▲ 0.03 (0.25%)
PPL 185.92 Decreased By ▼ -5.88 (-3.07%)
PRL 37.16 Decreased By ▼ -0.16 (-0.43%)
PTC 24.05 Increased By ▲ 0.85 (3.66%)
SEARL 100.29 Decreased By ▼ -0.60 (-0.59%)
SILK 1.15 No Change ▼ 0.00 (0%)
SSGC 38.51 Decreased By ▼ -1.20 (-3.02%)
SYM 14.75 Decreased By ▼ -0.28 (-1.86%)
TELE 7.73 Decreased By ▼ -0.11 (-1.4%)
TPLP 11.03 Decreased By ▼ -0.08 (-0.72%)
TRG 66.00 Decreased By ▼ -1.29 (-1.92%)
WAVESAPP 10.97 Decreased By ▼ -0.38 (-3.35%)
WTL 1.35 Decreased By ▼ -0.01 (-0.74%)
YOUW 3.78 Increased By ▲ 0.01 (0.27%)
BR100 12,826 Increased By 19.4 (0.15%)
BR30 38,861 Decreased By -842.2 (-2.12%)
KSE100 118,792 Decreased By -146.5 (-0.12%)
KSE30 36,779 Increased By 22.6 (0.06%)

Scientists in Britain and Thailand may have discovered why people who get infected again and again by dengue viruses suffer more severe symptoms like hemorrhagic fever and shock, and sometimes die. Transmitted by mosquitoes, there are four different dengue types. People who are infected again and again by a different dengue type tend to get severely ill, but experts have not been able to explain why.
In a study published in Science on May 07, researchers said they analysed blood samples donated by infected volunteers and found the human immune system produces a type of antibody called prM to fight off the dengue virus. But these were far from perfect.
"When a person who has already been infected with one strain of dengue virus encounters a different strain of dengue virus, the prM antibodies awakened during the first infection spring into action again," the researchers wrote in a statement. "Rather than protecting the body from the second infection, these prM antibodies help the virus to establish itself."
Led by Wanwisa Dejnirattisai and Gavin Screaton from the department of medicine at Imperial College London, the scientists said vaccine makers should steer clear of using prM antibodies. Designing a dengue vaccine or treatment is vital as global cases have shot up because of urbanisation, warmer temperatures and the constant movement of people - conditions that allow the Aedes aegypti mosquito, which carries the virus, to thrive.
The World Health Organisation has estimated that 2.5 billion people live in more than 100 endemic countries and areas where dengue viruses can be transmitted.
Between 50 and 100 million infections occur annually with 500,000 cases of dengue hemorrhagic fever (DHF) and 22,000 deaths, mainly among children. Dengue is expensive, costing an average of $1,394 for every hospitalised patient. At least 10 working days are lost in each case, according to the WHO. "Our new research gives us some key information about what is and what is not likely to work when trying to combat the dengue virus. We hope that our findings will bring scientists one step closer to creating an effective vaccine," the scientists wrote.

Copyright Reuters, 2010

Comments

Comments are closed.